Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.

Date publication

avril 2019

Journal

Journal of neurology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LHERMITTE Benoît , Pr DE SEZE Jérôme

Tous les auteurs :
Ayrignac X, Rigau V, Lhermitte B, Vincent T, de Champfleur NM, Carra-Dalliere C, Charif M, Collongues N, de Seze J, Hebbadj S, Ahle G, Oesterlé H, Cotton F, Durand-Dubief F, Marignier R, Vukusic S, Taithe F, Cohen M, Guennoc AM, Kerbrat A, Edan G, Carsin-Nicol B, Allou T, Sablot D, Thouvenot E, Ruet A, Magy L, Boncoeur-Martel MP, Labauge P, Kremer S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31016376

Résumé

The diagnosis of atypical inflammatory demyelinating lesions can be difficult. Brain biopsy is often required to exclude neoplasms. Moreover, the relationship between these lesions and multiple sclerosis and NMOSD is not clear.

Mots clés

Aquaporin-4, Atypical demyelinating lesions, Atypical inflammatory demyelinating syndrome, Histopathology, Immunopathology, Magnetic resonance imaging

Référence

J. Neurol.. 2019 Apr 23;: